Trial Profile
Three-year efficacy and safety of tenofovir disoproxil fumarate in nucleos(t)ide analog-naive and -experienced chronic hepatitis B patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 04 Feb 2016 New trial record
- 12 Jan 2016 Results published in the Journal of Gastroenterology and Hepatology